Amedisys, Inc. (AMED)
USD 96.0
(0.84%)
USD 96.0
(0.84%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 156.39 Million USD | 6.8% |
| 2022 | 180.77 Million USD | -28.24% |
| 2021 | 251.91 Million USD | 14.89% |
| 2020 | 219.26 Million USD | 23.55% |
| 2019 | 177.47 Million USD | 14.39% |
| 2018 | 155.14 Million USD | 97.58% |
| 2017 | 78.52 Million USD | 36.94% |
| 2016 | 57.34 Million USD | 725.57% |
| 2015 | -9.16 Million USD | -138.12% |
| 2014 | 24.04 Million USD | 115.52% |
| 2013 | -154.97 Million USD | -38.11% |
| 2012 | -112.2 Million USD | 76.17% |
| 2011 | -470.86 Million USD | -343.33% |
| 2010 | 193.51 Million USD | -16.14% |
| 2009 | 230.74 Million USD | 46.88% |
| 2008 | 157.1 Million USD | 62.69% |
| 2007 | 96.56 Million USD | 47.07% |
| 2006 | 65.65 Million USD | 31.04% |
| 2005 | 50.1 Million USD | 50.1% |
| 2004 | 33.37 Million USD | 132.79% |
| 2003 | 14.33 Million USD | 121.27% |
| 2002 | 6.48 Million USD | -13.17% |
| 2001 | 7.46 Million USD | 20630.56% |
| 2000 | 36 Thousand USD | 101.37% |
| 1999 | -2.62 Million USD | 91.03% |
| 1998 | -29.27 Million USD | -4879.25% |
| 1997 | -588 Thousand USD | -151.41% |
| 1996 | 1.14 Million USD | -18.3% |
| 1995 | 1.4 Million USD | 600.0% |
| 1994 | 200 Thousand USD | 300.0% |
| 1993 | -100 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 52.28 Million USD | 53.74% |
| 2024 Q2 | 64.11 Million USD | 22.62% |
| 2023 FY | 193.06 Million USD | 6.8% |
| 2023 Q4 | 34 Million USD | -19.43% |
| 2023 Q1 | 42.37 Million USD | -8.35% |
| 2023 Q2 | 37.79 Million USD | -10.82% |
| 2023 Q3 | 42.21 Million USD | 11.68% |
| 2022 Q4 | 46.23 Million USD | 18.77% |
| 2022 Q2 | 47.64 Million USD | -0.67% |
| 2022 Q1 | 47.96 Million USD | -0.41% |
| 2022 Q3 | 38.93 Million USD | -18.28% |
| 2022 FY | 180.77 Million USD | -28.24% |
| 2021 Q4 | 48.15 Million USD | -15.17% |
| 2021 FY | 251.91 Million USD | 14.89% |
| 2021 Q1 | 68.84 Million USD | 10.77% |
| 2021 Q2 | 78.13 Million USD | 13.49% |
| 2021 Q3 | 56.77 Million USD | -27.34% |
| 2020 Q3 | 63.31 Million USD | 26.8% |
| 2020 Q4 | 62.15 Million USD | -1.83% |
| 2020 Q2 | 49.93 Million USD | 13.82% |
| 2020 Q1 | 43.87 Million USD | 5.58% |
| 2020 FY | 219.26 Million USD | 23.55% |
| 2019 Q1 | 44.32 Million USD | 21.68% |
| 2019 FY | 177.47 Million USD | 14.39% |
| 2019 Q2 | 44.75 Million USD | 0.96% |
| 2019 Q3 | 46.84 Million USD | 4.68% |
| 2019 Q4 | 41.55 Million USD | -11.29% |
| 2018 Q1 | 36 Million USD | 21.04% |
| 2018 Q2 | 42.82 Million USD | 18.95% |
| 2018 Q4 | 36.42 Million USD | -8.68% |
| 2018 Q3 | 39.88 Million USD | -6.86% |
| 2018 FY | 155.14 Million USD | 97.58% |
| 2017 Q4 | 29.74 Million USD | 27.27% |
| 2017 FY | 78.52 Million USD | 36.94% |
| 2017 Q1 | 25.16 Million USD | 85.58% |
| 2017 Q2 | 240 Thousand USD | -99.05% |
| 2017 Q3 | 23.37 Million USD | 9638.75% |
| 2016 Q2 | 18.35 Million USD | 65.94% |
| 2016 Q4 | 13.56 Million USD | -5.56% |
| 2016 Q1 | 11.06 Million USD | -33.74% |
| 2016 Q3 | 14.35 Million USD | -21.78% |
| 2016 FY | 57.34 Million USD | 725.57% |
| 2015 Q3 | 16.71 Million USD | 7.65% |
| 2015 Q4 | 16.69 Million USD | -0.11% |
| 2015 Q2 | 15.52 Million USD | 126.72% |
| 2015 Q1 | -58.1 Million USD | -492.3% |
| 2015 FY | -9.16 Million USD | -138.12% |
| 2014 Q4 | 14.81 Million USD | -8.84% |
| 2014 Q2 | 12.56 Million USD | 164.18% |
| 2014 FY | 24.04 Million USD | 115.52% |
| 2014 Q3 | 16.24 Million USD | 29.35% |
| 2014 Q1 | -19.57 Million USD | -94.16% |
| 2013 Q2 | 3.79 Million USD | -9.02% |
| 2013 FY | -154.97 Million USD | -38.11% |
| 2013 Q4 | -10.08 Million USD | 93.47% |
| 2013 Q3 | -154.29 Million USD | -4167.81% |
| 2013 Q1 | 4.16 Million USD | 102.69% |
| 2012 FY | -112.2 Million USD | 76.17% |
| 2012 Q1 | 12.45 Million USD | -40.57% |
| 2012 Q2 | 15.54 Million USD | 24.82% |
| 2012 Q3 | 14.68 Million USD | -5.58% |
| 2012 Q4 | -154.89 Million USD | -1155.05% |
| 2011 Q3 | -557.31 Million USD | -1566.24% |
| 2011 FY | -470.86 Million USD | -343.33% |
| 2011 Q1 | 27.48 Million USD | -28.73% |
| 2011 Q4 | 20.96 Million USD | 103.76% |
| 2011 Q2 | 38.01 Million USD | 38.31% |
| 2010 Q1 | 61.71 Million USD | -2.9% |
| 2010 Q2 | 56.12 Million USD | -9.05% |
| 2010 Q3 | 37.1 Million USD | -33.89% |
| 2010 Q4 | 38.56 Million USD | 3.91% |
| 2010 FY | 193.51 Million USD | -16.14% |
| 2009 FY | 230.74 Million USD | 46.88% |
| 2009 Q4 | 63.55 Million USD | 4.65% |
| 2009 Q3 | 60.73 Million USD | 2.01% |
| 2009 Q2 | 59.54 Million USD | 26.9% |
| 2009 Q1 | 46.91 Million USD | 0.1% |
| 2008 Q3 | 43.63 Million USD | 12.61% |
| 2008 Q4 | 46.87 Million USD | 7.41% |
| 2008 FY | 157.1 Million USD | 62.69% |
| 2008 Q2 | 38.75 Million USD | 39.21% |
| 2008 Q1 | 27.83 Million USD | 6.69% |
| 2007 Q1 | 20.69 Million USD | 8.44% |
| 2007 FY | 96.56 Million USD | 47.07% |
| 2007 Q4 | 26.09 Million USD | 1.39% |
| 2007 Q3 | 25.73 Million USD | 7.05% |
| 2007 Q2 | 24.04 Million USD | 16.18% |
| 2006 Q4 | 19.08 Million USD | 5.05% |
| 2006 Q3 | 18.16 Million USD | 15.78% |
| 2006 Q2 | 15.68 Million USD | 23.34% |
| 2006 Q1 | 12.72 Million USD | 7.43% |
| 2006 FY | 65.65 Million USD | 31.04% |
| 2005 Q2 | 12.72 Million USD | 10.5% |
| 2005 FY | 50.1 Million USD | 50.1% |
| 2005 Q4 | 11.84 Million USD | -15.6% |
| 2005 Q3 | 14.02 Million USD | 10.28% |
| 2005 Q1 | 11.51 Million USD | 15.7% |
| 2004 Q2 | 8.08 Million USD | 17.06% |
| 2004 Q4 | 9.95 Million USD | 17.89% |
| 2004 Q3 | 8.44 Million USD | 4.42% |
| 2004 Q1 | 6.9 Million USD | 21.01% |
| 2004 FY | 33.37 Million USD | 132.79% |
| 2003 Q3 | 3.89 Million USD | 52.27% |
| 2003 Q2 | 2.55 Million USD | 17.03% |
| 2003 FY | 14.33 Million USD | 121.27% |
| 2003 Q1 | 2.18 Million USD | 216.17% |
| 2003 Q4 | 5.7 Million USD | 46.61% |
| 2002 Q3 | 2.4 Million USD | -18.99% |
| 2002 Q2 | 2.96 Million USD | -0.94% |
| 2002 FY | 6.48 Million USD | -13.17% |
| 2002 Q4 | -1.88 Million USD | -178.27% |
| 2002 Q1 | 2.99 Million USD | 0.77% |
| 2001 Q3 | 2.56 Million USD | 41.55% |
| 2001 Q4 | 2.97 Million USD | 15.93% |
| 2001 FY | 7.46 Million USD | 20630.56% |
| 2001 Q1 | 3.22 Million USD | 27.21% |
| 2001 Q2 | 1.81 Million USD | -43.81% |
| 2000 FY | 36 Thousand USD | 101.37% |
| 2000 Q4 | 2.53 Million USD | 394.76% |
| 2000 Q1 | -816 Thousand USD | 62.91% |
| 2000 Q3 | -859 Thousand USD | -4.63% |
| 2000 Q2 | -821 Thousand USD | -0.61% |
| 1999 Q3 | -600 Thousand USD | 25.0% |
| 1999 FY | -2.62 Million USD | 91.03% |
| 1999 Q4 | -2.2 Million USD | -266.67% |
| 1999 Q2 | -800 Thousand USD | 32.15% |
| 1999 Q1 | -1.17 Million USD | 90.32% |
| 1998 Q4 | -12.17 Million USD | -24.27% |
| 1998 Q1 | -3.7 Million USD | -48.71% |
| 1998 FY | -29.27 Million USD | -4879.25% |
| 1998 Q2 | -2.7 Million USD | 27.03% |
| 1998 Q3 | -9.8 Million USD | -262.96% |
| 1997 Q3 | 600 Thousand USD | -14.29% |
| 1997 FY | -588 Thousand USD | -151.41% |
| 1997 Q4 | -2.48 Million USD | -514.67% |
| 1997 Q1 | 600 Thousand USD | 317.41% |
| 1997 Q2 | 700 Thousand USD | 16.67% |
| 1996 Q2 | 500 Thousand USD | 25.0% |
| 1996 Q3 | 300 Thousand USD | -40.0% |
| 1996 Q4 | 143.74 Thousand USD | -52.09% |
| 1996 FY | 1.14 Million USD | -18.3% |
| 1996 Q1 | 400 Thousand USD | 0.0% |
| 1995 Q2 | 300 Thousand USD | 50.0% |
| 1995 Q1 | 200 Thousand USD | 101.12% |
| 1995 FY | 1.4 Million USD | 600.0% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| 1995 Q3 | 200 Thousand USD | -33.33% |
| 1994 FY | 200 Thousand USD | 300.0% |
| 1994 Q4 | -17.8 Million USD | -373.85% |
| 1994 Q1 | 200 Thousand USD | 101.71% |
| 1994 Q2 | - USD | -100.0% |
| 1994 Q3 | 6.5 Million USD | 0.0% |
| 1993 FY | -100 Thousand USD | 0.0% |
| 1993 Q3 | 2.3 Million USD | -51.06% |
| 1993 Q2 | 4.7 Million USD | 2.17% |
| 1993 Q1 | 4.6 Million USD | 0.0% |
| 1993 Q4 | -11.7 Million USD | -608.7% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 69.128% |
| Addus HomeCare Corporation | 90.95 Million USD | -71.945% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -1549.204% |
| Astrana Health, Inc. | 84.61 Million USD | -84.834% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -1837.488% |
| IMAC Holdings, Inc. | -6.37 Million USD | 2553.044% |
| biote Corp. | 28.65 Million USD | -445.744% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 1371.079% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | -38.754% |
| COMPASS Pathways plc | -136.91 Million USD | 214.224% |
| DocGo Inc. | 15.05 Million USD | -938.819% |
| The Ensign Group, Inc. | 255.36 Million USD | 38.757% |
| Healthcare Services Group, Inc. | 62.35 Million USD | -150.8% |
| InnovAge Holding Corp. | -23.18 Million USD | 774.694% |
| The Joint Corp. | -2.07 Million USD | 7644.015% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 182.69% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 1095.903% |
| ModivCare Inc. | -139.94 Million USD | 211.753% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -370133.417% |
| Option Care Health, Inc. | 314.59 Million USD | 50.287% |
| P3 Health Partners Inc. | -167.86 Million USD | 193.169% |
| P3 Health Partners Inc. | -167.86 Million USD | 193.169% |
| The Pennant Group, Inc. | 25.16 Million USD | -521.376% |
| Surgery Partners, Inc. | 328 Million USD | 52.319% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 5516.057% |
| Talkspace, Inc. | -23.2 Million USD | 773.851% |
| Talkspace, Inc. | -23.2 Million USD | 773.851% |
| The Oncology Institute, Inc. | -77.01 Million USD | 303.062% |
| The Oncology Institute, Inc. | -77.01 Million USD | 303.062% |